The Diagnostic Function of OCT in Diabetic Maculopathy
Figure 3
(a) Colour-coded macular thickness maps revealing the change in retinal thickness between the examinations. The second map was obtained 2 weeks after treatment with Ranibizumab. Resolution of DME is evident but the corresponding thickness deviation map shows that the anatomical improvement is also related to the central macular atrophy which may limit the visual acuity. (b) Corresponding SDOCT tomograms presenting the disappearance of nearly all intraretinal cystoid spaces.
